跳至主要内容
临床试验/CTRI/2024/09/073420
CTRI/2024/09/073420尚未招募不适用

A combination therapy of norepinephrine and milrinone as a first-line agent in fluid refractory Pediatric septic shock – a randomized controlled trial

AIIMS RISHIKESH1 个研究点 分布在 1 个国家目标入组 164 人开始时间: 2024年10月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
164
试验地点
1
主要终点
The proportion of children attaining shock resolution (achieving all therapeutic endpoints of shock) at 6 hours

研究概览

简要总结

The RCT will evaluate the efficacy  of  a combination therapy of Norepinephrine and Milrinone as a first-line agent in fluid refractory pediatric septic shock resulting in shock reversal in a greater proportion of children compared to the use of Epinephrine alone in children age one month to 18 years Shock resolution is defined as attainment of all therapeutic endpoints as per surviving sepsis campaign international guidelines.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
1.00 Month(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • Children aged one month to 18 years with septic shock, defined as children with suspect or confirmed sepsis and cardiovascular dysfunction, who are fluid refractory, defined as the persistence of features of poor perfusion even after 40 ml/kg of fluid boluses or having clinical features of fluid overload.

排除标准

  • Children with Fulminant myocarditis
  • Children with Congenital heart disease, cardiomyopathy
  • Children already on inotropes at the time of enrolment.

结局指标

主要结局

The proportion of children attaining shock resolution (achieving all therapeutic endpoints of shock) at 6 hours

时间窗: Six hours

次要结局

  • 1. Proportion of children achieving therapeutic endpoints at 1st and 24 hours of resuscitation(2. All-cause mortality at discharge or day 28 (whichever is earlier) and duration of PICU stay)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Man Singh Parihar

AIIMS Rishikesh

研究点 (1)

Loading locations...

相似试验